ACETO to Present at the Oppenheimer 23rd Annual Healthcare Conference
PORT WASHINGTON, N.Y., Nov. 28, 2012 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that Salvatore Guccione, President and COO, and Doug Roth, Chief Financial Officer, are scheduled to present at the Oppenheimer 23rd Annual Healthcare Conference on Thursday, December 13, 2012 in New York City.
|Event:||Oppenheimer 23rd Annual Healthcare Conference|
|Date:||Thursday, December 13, 2012|
|Time:||2:45 PM – 3:15 PM ET|
|Place:||Waldorf-Astoria, New York City|
An audio Webcast of the Company's presentations will be available by visiting the investor relations section of ACETO's website at www.ACETO.com. A replay of the presentation will be available for 30 days. Management will also be available for one-on-one meetings at the conference.
ACETO Corporation, incorporated in 1947, is a global leader in the marketing, sales and distribution of products for Human Health (finished dosage form generics and nutraceutical products), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products). With business operations in nine countries, ACETO distributes over 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. ACETO's global operations, including a staff of 26 in China and 12 in India, are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities.
The ACETO Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13058
CONTACT: Investor Relations Contact: Amy Glynn The Ruth Group (646) 536-7023 email@example.com